- Home
- UNCY vs IDN Comparison
UNCY vs IDN Comparison
Compare UNCY & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- IDN
- Stock Information
- Founded
- UNCY 2016
- IDN 1994
- Country
- UNCY United States
- IDN United States
- Employees
- UNCY N/A
- IDN N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- IDN Computer Software: Prepackaged Software
- Sector
- UNCY Health Care
- IDN Technology
- Exchange
- UNCY Nasdaq
- IDN Nasdaq
- Market Cap
- UNCY 91.0M
- IDN 120.5M
- IPO Year
- UNCY 2021
- IDN 1999
- Fundamental
- Price
- UNCY $4.55
- IDN $5.37
- Analyst Decision
- UNCY Strong Buy
- IDN Strong Buy
- Analyst Count
- UNCY 4
- IDN 3
- Target Price
- UNCY $63.75
- IDN $5.83
- AVG Volume (30 Days)
- UNCY 1.5M
- IDN 453.1K
- Earning Date
- UNCY 08-13-2025
- IDN 08-07-2025
- Dividend Yield
- UNCY N/A
- IDN N/A
- EPS Growth
- UNCY N/A
- IDN N/A
- EPS
- UNCY N/A
- IDN N/A
- Revenue
- UNCY N/A
- IDN $20,211,000.00
- Revenue This Year
- UNCY N/A
- IDN $9.35
- Revenue Next Year
- UNCY $1,458.53
- IDN $13.05
- P/E Ratio
- UNCY N/A
- IDN N/A
- Revenue Growth
- UNCY N/A
- IDN 4.55
- 52 Week Low
- UNCY $2.02
- IDN $1.92
- 52 Week High
- UNCY $11.00
- IDN $6.49
- Technical
- Relative Strength Index (RSI)
- UNCY 39.53
- IDN 56.10
- Support Level
- UNCY $4.76
- IDN $5.03
- Resistance Level
- UNCY $7.15
- IDN $5.66
- Average True Range (ATR)
- UNCY 0.97
- IDN 0.32
- MACD
- UNCY -0.28
- IDN -0.11
- Stochastic Oscillator
- UNCY 7.37
- IDN 36.17
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.